Foscenvivint
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Foscenvivint, covering 2025-03-17 to 2025-03-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection with Hemophilia (OP-724-H201) [Phase 2]